OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution
A. Hunter Shain, Nancy M. Joseph, Richard Yu, et al.
Cancer Cell (2018) Vol. 34, Iss. 1, pp. 45-55.e4
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
David E. Elder, Boris C. Bastian, Ian A. Cree, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 144, Iss. 4, pp. 500-522
Open Access | Times Cited: 367

Targeting telomerase for cancer therapy
Adam N. Guterres, Jessie Villanueva
Oncogene (2020) Vol. 39, Iss. 36, pp. 5811-5824
Open Access | Times Cited: 196

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
Roy Rabbie, Peter M. Ferguson, Christian Molina‐Aguilar, et al.
The Journal of Pathology (2018) Vol. 247, Iss. 5, pp. 539-551
Open Access | Times Cited: 183

The genetic evolution of metastatic uveal melanoma
A. Hunter Shain, Mette Bagger, Richard Yu, et al.
Nature Genetics (2019) Vol. 51, Iss. 7, pp. 1123-1130
Open Access | Times Cited: 182

Melanoma models for the next generation of therapies
E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 610-631
Open Access | Times Cited: 158

Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma
Nazia Riaz, Anne Huibers, Stanley P. L. Leong, et al.
Annals of Surgical Oncology (2025)
Open Access | Times Cited: 2

Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation
Hanlin Zeng, Aparna Jorapur, A. Hunter Shain, et al.
Cancer Cell (2018) Vol. 34, Iss. 1, pp. 56-68.e9
Open Access | Times Cited: 124

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours
Ellen Brenner, Barbara F. Schörg, Fatima Ahmetlić, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 109

The genomic landscapes of individual melanocytes from human skin
Jessica Tang, Eleanor Fewings, Darwin Chang, et al.
Nature (2020) Vol. 586, Iss. 7830, pp. 600-605
Open Access | Times Cited: 102

The landscape of driver mutations in cutaneous squamous cell carcinoma
Darwin Chang, A. Hunter Shain
npj Genomic Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 91

TERTgene: its function and dysregulation in cancer
Andrew J. Colebatch, Alexander Dobrovic, Wendy A. Cooper
Journal of Clinical Pathology (2019) Vol. 72, Iss. 4, pp. 281-284
Open Access | Times Cited: 79

Translating insights into tumor evolution to clinical practice: promises and challenges
Matthew W. Fittall, Peter Van Loo
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 77

Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
Eran Hodis, Elena Torlai Triglia, John Kwon, et al.
Science (2022) Vol. 376, Iss. 6592
Open Access | Times Cited: 48

Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma
Inger Z. M. Kreuger, Roderick C. Slieker, Tim van Groningen, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 1, pp. 18-25.e1
Open Access | Times Cited: 38

Melanoma biology and treatment: a review of novel regulated cell death-based approaches
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11

The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma
Muzhou Wu, Ailish Hanly, Frederick Gibson, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 9

The genetic evolution of acral melanoma
Meng Wang, Satoshi Fukushima, Yi‐Shuan Sheen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Extracellular‐signal‐regulated kinase/mitogen‐activated protein kinase signaling as a target for cancer therapy: an updated review
Masoud Najafi, Amirhossein Ahmadi, Keywan Mortezaee
Cell Biology International (2019) Vol. 43, Iss. 11, pp. 1206-1222
Closed Access | Times Cited: 69

Biology of Melanoma
Stephen M. Ostrowski, David E. Fisher
Hematology/Oncology Clinics of North America (2020) Vol. 35, Iss. 1, pp. 29-56
Closed Access | Times Cited: 67

Molecular Genomic Profiling of Melanocytic Nevi
Andrew J. Colebatch, Peter M. Ferguson, Felicity Newell, et al.
Journal of Investigative Dermatology (2019) Vol. 139, Iss. 8, pp. 1762-1768
Open Access | Times Cited: 66

TERT promoter mutations and telomeres during tumorigenesis
Franziska K. Lorbeer, Dirk Hockemeyer
Current Opinion in Genetics & Development (2020) Vol. 60, pp. 56-62
Closed Access | Times Cited: 52

Redox Regulation in Cancer Cells during Metastasis
Alpaslan Tasdogan, Jessalyn M. Ubellacker, Sean J. Morrison
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2682-2692
Open Access | Times Cited: 47

Loss of Ambra1 promotes melanoma growth and invasion
Luca Di Leo, Valérie Bodemeyer, Francesca Maria Bosisio, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46

Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation
Brandon Murphy, Elizabeth M. Terrell, Venkat R. Chirasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top